# Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants

> **NCT00342628** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 301 (actual)

## Conditions studied

- Typhoid Fever

## Interventions

- **BIOLOGICAL:** Vi-rEPA conjugate vaccine for typhoid fever
- **BIOLOGICAL:** Hib-TT
- **BIOLOGICAL:** DTP

## Key facts

- **NCT ID:** NCT00342628
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-04
- **Final completion:** 2011-01
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2012-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00342628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00342628, "Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00342628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*